ENTRY       D00998                      Drug
NAME        Neostigmine methylsulfate (JP18/USP);
            Bloxiverz (TN);
            Prostigmin (TN)
PRODUCT     BLOXIVERZ (Exela Pharma Sciences)
            BLOXIVERZ (Exela Pharma Sciences)
            BLOXIVERZ (Exela Pharma Sciences)
            NEOSTIGMINE METHYLSULFATE (Fresenius Kabi USA)
            NEOSTIGMINE METHYLSULFATE (Fresenius Kabi USA)
            NEOSTIGMINE METHYLSULFATE (Fresenius Kabi USA)
            NEOSTIGMINE METHYLSULFATE (Fresenius Kabi USA)
  GENERIC   NEOSTIGMINE (Dr.Reddy's Laboratories)
            NEOSTIGMINE (Medical Purchasing Solutions)
            NEOSTIGMINE METHYLSULFATE (Amneal Pharmaceuticals LLC)
            NEOSTIGMINE METHYLSULFATE (Amphastar Pharmaceuticals)
            NEOSTIGMINE METHYLSULFATE (BE Pharmaceuticals)
            NEOSTIGMINE METHYLSULFATE (Camber Pharmaceuticals)
            NEOSTIGMINE METHYLSULFATE (Caplin Steriles Limited)
            NEOSTIGMINE METHYLSULFATE (Civica)
            NEOSTIGMINE METHYLSULFATE (Civica)
            NEOSTIGMINE METHYLSULFATE (Dr.Reddys Laboratories)
            NEOSTIGMINE METHYLSULFATE (General Injectables and Vaccines)
            NEOSTIGMINE METHYLSULFATE (Gland Pharma Limited)
            NEOSTIGMINE METHYLSULFATE (HF Acquisition Co LLC)
            NEOSTIGMINE METHYLSULFATE (Henry Schein)
            NEOSTIGMINE METHYLSULFATE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            NEOSTIGMINE METHYLSULFATE (Hikma Pharmaceuticals USA)
            NEOSTIGMINE METHYLSULFATE (Hikma Pharmaceuticals USA)
            NEOSTIGMINE METHYLSULFATE (Hikma Pharmaceuticals USA)
            NEOSTIGMINE METHYLSULFATE (Indoco Remedies Limited)
            NEOSTIGMINE METHYLSULFATE (Medical Purchasing Solutions)
            NEOSTIGMINE METHYLSULFATE (Medical Purchasing Solutions)
            NEOSTIGMINE METHYLSULFATE (Medical Purchasing Solutions)
            NEOSTIGMINE METHYLSULFATE (Meitheal Pharmaceuticals)
            NEOSTIGMINE METHYLSULFATE (Nivagen Pharmaceuticals)
            NEOSTIGMINE METHYLSULFATE (Par Pharmaceutical)
            NEOSTIGMINE METHYLSULFATE (Sagent Pharmaceuticals)
            NEOSTIGMINE METHYLSULFATE (Somerset Therapeutics)
            NEOSTIGMINE METHYLSULFATE (Xellia Pharmaceuticals USA LLC)
            NEOSTIGMINE METHYLSULFATE (Xiromed LLC)
FORMULA     C12H19N2O2. CH3SO4
EXACT_MASS  334.1199
MOL_WEIGHT  334.3886
CLASS       Neuropsychiatric agent
             DG01595  Cholinesterase inhibitor
              DG01593  Acetylcholinesterase inhibitor
             DG01719  Parasympathomimetic agent
REMARK      Same as: C08200
            Therapeutic category: 1233
            ATC code: N07AA01 S01EB06
            Chemical structure group: DG00987
            Product (DG00987): D00995<JP> D00998<JP/US>
            Product (mixture): D04114<JP> D09186<JP>
EFFICACY    Parasympathomimetic, Acetylcholinesterase inhibitor
COMMENT     Physostigmine derivative
TARGET      ACHE [HSA:43] [KO:K01049]
  PATHWAY   hsa00564(43)  Glycerophospholipid metabolism
            hsa04725(43)  Cholinergic synapse
INTERACTION  
STR_MAP     map07220  Cholinergic and anticholinergic drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07A PARASYMPATHOMIMETICS
                N07AA Anticholinesterases
                 N07AA01 Neostigmine
                  D00998  Neostigmine methylsulfate (JP18/USP) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EB Parasympathomimetics
                 S01EB06 Neostigmine
                  D00998  Neostigmine methylsulfate (JP18/USP) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              12  Agents affecting peripheral nervous system
               123  Autonomic nervous system agents
                1233  Neostigmines
                 D00998  Neostigmine methylsulfate (JP18/USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for ophthalmologic use
              62 General eye drops
               D00998  Neostigmine methylsulfate (JP18/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Third-class OTC drugs
              Inorganic and organic chemicals
               Neostigmine
                D00998  Neostigmine methylsulfate (JP18/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01595  Cholinesterase inhibitor
               DG01593  Acetylcholinesterase inhibitor
                DG00987  Neostigmine
                 D00998  Neostigmine methylsulfate
              DG01719  Parasympathomimetic agent
               DG00987  Neostigmine
                D00998  Neostigmine methylsulfate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Carboxylic-ester hydrolases
                ACHE
                 D00998  Neostigmine methylsulfate (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00998  Neostigmine methylsulfate
              D00998  Neostigmine methylsulfate injection
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01595  Cholinesterase inhibitor
               DG01593  Acetylcholinesterase inhibitor
                DG00987  Neostigmine
              DG01719  Parasympathomimetic agent
               DG00987  Neostigmine
DBLINKS     CAS: 51-60-5
            PubChem: 7848061
            ChEBI: 7516
            LigandBox: D00998
            NIKKAJI: J262.808B
ATOM        22
            1   C8y C    21.6932  -17.0217
            2   C8x C    22.9128  -16.3157
            3   C8x C    21.6932  -18.4279
            4   O7a O    20.4737  -16.3214
            5   C8y C    24.1207  -17.0217
            6   C8x C    22.9128  -19.1281
            7   C7a C    19.2600  -17.0274
            8   C8x C    24.1207  -18.4221
            9   N1d N    25.3402  -16.3157 #+
            10  N1c N    18.0405  -16.3274
            11  O6a O    19.2600  -18.4338
            12  C1a C    26.7988  -15.3937
            13  C1a C    24.6750  -15.2537
            14  C1a C    26.1630  -17.5234
            15  C1a C    16.8326  -17.0334
            16  C1a C    18.0405  -14.9210
            17  S4a S    32.7856  -17.4302
            18  O2a O    31.4201  -17.4243
            19  O1d O    32.7739  -18.7022
            20  O1d O    32.7272  -15.8138
            21  O1d O    34.1686  -17.4302 #-
            22  C1a C    30.6791  -16.3389
BOND        21
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     5   8 2
            8     5   9 1
            9     7  10 1
            10    7  11 2
            11    9  12 1
            12    9  13 1
            13    9  14 1
            14   10  15 1
            15   10  16 1
            16    6   8 1
            17   17  18 1
            18   17  19 2
            19   17  20 2
            20   17  21 1
            21   18  22 1
///
